Recent developments in livestock and wildlife brucellosis vaccination

OIE Revue Scientifique et Technique

Volumn 32, Issue 1, 2013, Pages 207-217

  Olsen, S C ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Adaptive immunity; Brucellosis; DNA vaccine; Innate immunity; Nanoparticle; Vaccine

Indexed keywords

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS;

EID: 84879437850     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.32.1.2201     Document Type: Article

References (53)

1. Arenas-Gamboa A.M., Ficht T.A., Davis D.S., Elzer PH., Wong-Gonzalez A. & Rice-Ficht A.C. (2009). - Enhanced immune response of red deer (Cervus elaphus) to live RB51 vaccine strain using composite microspheres. J. Wildl. Dis., 45, 165-173.
2. Barrio M.B., Grilló M.J., Muñoz RM., Jacques I., González D., de Miguel M.J., Marin CM., Barberán M., Letesson J.-J., Gorvel J.P, Moriyón I., Balseo J.M. & Zygmunt M.S. (2008). - Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep. Vaccine, 27, 1741-1749.
3. Bimczok D. & Rothkotter H.J. (2005). - Lymphocyte migration studies. Vet. Res., 37, 325-338.
4. Blasco J.M. (2010). - Control and eradication strategies for Brucella melilensis infection in sheep and goats. Priloži, 31,145-165.
5. Buddie B.M., Wedlock D.N., Denis M. & Skinner M.A. (2005). Identification of immune response correlates for protection against bovine tuberculosis. Vei. Immunol. Immunopathol, 108, 45-51.
6. Caporale V, Bonfini B., Giannatale E.D., Di Provvido A., Forcella S., Giovanni A., Tittarelli M. & Scacchia M. (2010). Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo. Vet. ital., 46 (1), 13-19.
7. Cheville N.F, Stevens M.G., Jensen A.E., Tatum FM. & Hailing S.M. (1993). - Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of B. abortus. Am. J. vet. Res., 54, 1591-1597.
8. Clapp B., Walters N., Thornburg T., Hoyt T., Yangh X. & Pascual D.W (2011). - DNA vaccination of bison to brucellar antigens elicits elevated antibody and IFN-γ responses. J. Wildl. Dis., 47, 501-510.
9. Davis D.S., Templeton J.W, Ficht TA., Huber J.D., Angus R.D. & Adams LG. (1991). - Brucella abortus in bison. II. Evaluation of strain 19 vaccination of pregnant cows. J. Wildl. Dis., 27, 258-264.
10. Demento S.L., Cui W, Criscione J.M., Stern E., Tulipan J., Kaech S.M. & Fahmy T.M. (2012). - Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. Bwmaterials, 33, 4957-4964.
11. Deqiu S., Donglou X. & Jiming Y. (2002). - Epidemiology and control of brucellosis in China. Vet. Microbiol., 90, 168-182.
12. Dhama K., Mahendran M., Gupta PK. & Rai A. (2008). - DNA vaccines and their applications in veterinary practice: current perspectives. Vet. Res. Commun., 32, 341-356.
13. Diptee M.D., Adesiyun A.A., Asgarali Z., Campbell M. & Fosgate G.T. (2005). - Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine. Vet. Immunol. Immunopathol, 106 (3-4), 209-220.
14. Edmonds M.D., Cloeckaert A., Hagius S.D., Samartino L.E., Fulton WT, WalkerJ.V, Enright FM., Booth NJ. & Elzer PH. (2002). - Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant. Res. vet. Sci., 72 (3), 235-239.
15. Elias D., Alruffo H. & Britton S. (2005). - Induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans, roy. Soc. trop. Med. Hyg., 99, 363-368.
16. Elzer P.H., Enright EM., McQuiston J.R., Boyle S.M. & Schurig G.G. (1998). - Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res. vei. Sci., 64, 259-260.
17. Fiorentino M.A., Campos E., Cravero S., Arese A., Paolicchi E, Campero C. & Rossetti O. (2008). - Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2. Vet. Microbiol., 132, 302-311.
18. Fosgate G.T, Adesiyun A.A., Hird D.W., Johnson WO., Hietala S.K., Schurig G.G., Ryan J. & Diptee M.D. (2003). - Evaluation of brucellosis RB51 vaccine for domestic water buffalo (Bubalus bubalis) in Trinidad. Prev. vet. Med., 58,211-225.
19. Gicheru M.M., Olobo J O., Anjili CO., Orago A.S., Modabber E & Scott R (2001). - Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Inject. Immun., 69, 245-251.
20. Hu X.D., Yu D.H., Chen S.T., Li S.X. & Cai H. (2009). - A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle. DNA Cell Biol, 28, 191-199.
21. Ivanov A.V, Salmakov K.M., Olsen S.C. & Plumb G.E. (2011). - A live vaccine from Brucella abortus strain 82 for control of cattle brucellosis in the Russian Federation. Anim. Hlth Res. Rev., 12, 113-121.
22. Jelastopulu E., Bikas C, Petropoulos C. & Leotsinidis M. (2008). - Incidence of human brucellosis in a rural area in Western Greece after the implementation of a vaccination programme against animal brucellosis. BMC Public Hlth, 8, 241.
23. Kagan J.C. & Iwasaki A. (2012). - Phagosome as the organelle linking innate and adaptive immunity. Traffic, 13 (8), 1053-1061.
24. Kahl-McDonagh M.M., Elzer PH., Hagius S.D., Walker J.V, Perry Q.L., Seabury CM., den Hartigh A.B., Tsolis R.M., Adams L.G., Davis D.S. & Ficht T.A. (2006). - Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine, 24,5169-5177.
25. Kreeger T.J., Cook WE., Edwards WH., Elzer PH. & Olsen S.C (2002). - Brucella abortus strain RB51 vaccination in elk II. Failure of high dosage to prevent abortion. J. Wildl. Dis., 38, 27-31.
26. Kreeger T.J., Miller M.W, Wild M., Elzer PH. & Olsen S.C. (2000). - Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk. ]. Wildl. Dis., 36, 477-483.
27. Liu J., Liu S. &Cao X. (2012). - Highlights of the advances in basic immunology in 2011. Cell Molec. Immunol, 9, 197-207.
28. Mahapatro A. & Singh D.K. (2011). - Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanotechnology, 9, 55.
29. Martins H., Garin-Bastuji B., Lima F., Flor L., Pina Fonseca A. & Boinas E (2009). - Eradication of bovine brucellosis in the Azores, Portugal: outcome of a 5-year programme (2002-2007) based on test-and-slaughter and RB51 vaccination. Prev. vet. Med., 90 (1-2), 80-39.
30. Moon J.J., Suh H., Polhemus M.E., Ockenhouse CE, Yadava A. & Irvine DJ. (2012). - Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine. PLoS ONE, 7, e31472.
31. Mott G.A., Wilson R., Fernando A., Robinson A., MacGregor R, Kennedy D., Schaap D., Matthews J.B. & Matthews K.R. (2011). - Targeting cattle-borne zoonoses and cattle pathogens using a novel trypanosomatid-based delivery system. PLoS Pathog., 7,1-9.
32. Oh J.E. & Lee H.K. (2012). - Modulation of pathogen recognition by autophagy. Front. Immunol, 3, 1-8.
33. Oliveira S.C, Giamartolomei G.H. & Cassataro J. (2011). -Confronting the barriers to develop novel vaccines against brucellosis. Expert Rev. Vaccines, 10, 1291-1305.
34. Olsen S.C. & Hennager S.G. (2010). - Immune responses and protection against experimental Brucella suis biovar 1 challenge in nonvaccinated or B. abortus strain RB51-vaccinated cattle. Clin, vaccine Immunol, 17, 1891-1895.
35. Olsen S.C. & Johnson C.S. (2012). - Efficacy of dan or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challenge. Clin, vaccine Immunol, 19, 886-890.
36. Olsen S.C, Boyle S.M., Schurig G.G. & Sriranganathan N.N. (2009). - Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin. vacane Immunol, 16, 535-540.
37. Olsen S.C, Fach S.J., Palmer M.V, Sacco R.E., Stoffregen WS. & Waters WR. (2006). - Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19. Clin, vaccine Immunol, 13, 1098-1103.
38. Olsen S.C, Jensen A.E., Stoffregen WC. & Palmer M.V (2003). - Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis. Res. vet. Sci., 74, 17-22.
39. Paryam J., Zhou WZ, Prabha S., Sahoo S.K. & Labhasentvar V (2002). - Rapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB]., 16, 1217-1226.
40. Ramnanan A. (2010). - Response of water buffalo (Bubalus bubalis) to experimental challenge with Brucella abortus biovar 1 following vaccination with two dosage of Brucella abortus strain RB51. M. Phil, thesis submitted to the University of the West Indies, St Augustine Campus, Trinidad and Tobago.
41. Rittig M.G., Kaufmann A., Robins A., Shaw B., Sprenger H., Gensa D., Foulongne V, Rouot B. & Dornand J. (2003). - Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J. Leukoc. Biol, 74,1045-1055.
42. Rivers R., Andrews E., González-Smith A., Donoso G. & Oñate A. (2006). - Brucella abortus: immunity, vaccines and prevention strategies based on nucleic acids. Arch. Med. vet., 38, 7-18.
43. Roth E, Zinsstag J., Orkhon D., Chimedj-Ochir G., Hutton G., Cosivi O., Carrin G. & Otte J. (2003). - Human health benefits from livestock vaccination for brucellosis: case study. Bull. WHO, 81, 867-876.
44. Sáez D., Guzmán I., Andrews E., Cabera A. & Oñate A. (2008). - Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle. Vet. Microbiol, 129, 396-403.
45. Scheerlinck J.P & Greenwood D.L.V (2008). - Virus-sized vaccine delivery systems. Drug Discov. Today, 13, 882-887.
46. Stoffregen WC, Johnson C.A. & Olsen S.C. (2013). -Immunogenicity and safety of a natural rough mutant of B. suis as a vaccine for swine. Rev. vet. Sci. (in press).
47. Thakur A., Pedersen L.E. & Jungersen G. (2012). - Immune markers and correlates of protection for vaccine-induced immune responses. Vaccine, 30, 4907-4920.
48. Torrado E. & Cooper A.M. (2011). - IL-17 and Th17 cells in tuberculosis. Cytokine Growth Fact. Rev., 21, 455-462.
49. Underhill D.M., Ozinsky A., Hajar A.M., Stevens A., Wilson C.B., Bassetti M. & Aderem A. (1999). - The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 401, 811-816.
50. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M. & Schurig G.G. (2000). - Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Inject. Immun., 68 (6), 3286-3289.
51. Ward D., Jackson R., Karomatullo H., Khakimov T., Kurbonov K., Amirbekov M., Stack J., El-Idrissi A. & Heuer C. (2012). - Brucellosis control in Tajikistan using Revi vaccine: change in seroprevalence in small ruminants from 2004 to 2009. Vet. Ree, 170,100.
52. Wyckoff J.H., Howland J.L, Scott CM., Smith R.A. & Confer A.W (2005). - Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Vet. Microbiol., Ill, 77-87.
53. Zinsstag J., Roth E, Orkhon D., Chimed-Ochir G., Nansalmaa M., Kolar J. & Vounatsou P. (2005). - A model of animal-human brucellosis transmission in Mongolia. Prev. vet. Med., 69, 77-95.